Protection against Shiga Toxins
AbstractShiga toxins consist of an A-moiety and five B-moieties able to bind the neutral glycosphingolipid globotriaosylceramide (Gb3) on the cell surface. To intoxicate cells efficiently, the toxin A-moiety has to be cleaved by furin and transported retrogradely to the Golgi apparatus and to the endoplasmic reticulum. The enzymatically active part of the A-moiety is then translocated to the cytosol, where it inhibits protein synthesis and in some cell types induces apoptosis. Protection of cells can be provided either by inhibiting binding of the toxin to cells or by interfering with any of the subsequent steps required for its toxic effect. In this article we provide a brief overview of the interaction of Shiga toxins with cells, describe some compounds and conditions found to protect cells against Shiga toxins, and discuss whether they might also provide protection in animals and humans. View Full-Text
A printed edition of this Special Issue is available here.
Share & Cite This Article
Kavaliauskiene, S.; Dyve Lingelem, A.B.; Skotland, T.; Sandvig, K. Protection against Shiga Toxins. Toxins 2017, 9, 44.
Kavaliauskiene S, Dyve Lingelem AB, Skotland T, Sandvig K. Protection against Shiga Toxins. Toxins. 2017; 9(2):44.Chicago/Turabian Style
Kavaliauskiene, Simona; Dyve Lingelem, Anne B.; Skotland, Tore; Sandvig, Kirsten. 2017. "Protection against Shiga Toxins." Toxins 9, no. 2: 44.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.